Trial Outcomes & Findings for Effects of Warmed, Humidified CO2 Insufflation on Body Core Temperature and Cytokine Response (NCT NCT02586974)

NCT ID: NCT02586974

Last Updated: 2025-01-30

Results Overview

body core temperature of patients undergoing robot-assisted radical prostatectomy (RARP), measured with a disposable esophageal probe

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

64 participants

Primary outcome timeframe

Intraoperative at hourly intervals

Results posted on

2025-01-30

Participant Flow

All patients undergoing RARP at Città della Salute e della Scienza Hospital between September 2015 and June 2016 were screened for inclusion.

Exclusion criteria were as follows: age \>80 years, ASA status \>3, allergic status needing corticosteroid premedication, refusal to sign the informed consent, cognitive disability, conversion to open surgery.

Participant milestones

Participant milestones
Measure
Group H+WB
32 patients will receive warmed, humidified CO2 insufflation with the Humigard® device, along with the hot air warming blanket used as a routine in our institution (forced air warming blanket at 38°C : Bear Hugger®) Humigard: warmed and humidified CO2 insufflation
Group WB
32 patients will receive standard CO2 insufflation, along with the hot air warming blanket used as a routine in our institution (forced air warming blanket at 38°C : Bear Hugger® and a standard insufflation with non-humidified, non-heated CO2)
Overall Study
STARTED
32
32
Overall Study
COMPLETED
32
32
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effects of Warmed, Humidified CO2 Insufflation on Body Core Temperature and Cytokine Response

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group H+WB
n=32 Participants
32 patients will receive warmed, humidified CO2 insufflation with the Humigard® device, along with the hot air warming blanket used as a routine in our institution (forced air warming blanket at 38°C : Bear Hugger®) Humigard: warmed and humidified CO2 insufflation
Group WB
n=32 Participants
32 patients will receive standard CO2 insufflation, along with the hot air warming blanket used as a routine in our institution (forced air warming blanket at 38°C : Bear Hugger® and a standard insufflation with non-humidified, non-heated CO2)
Total
n=64 Participants
Total of all reporting groups
Age, Continuous
66.4 years
STANDARD_DEVIATION 7.0 • n=5 Participants
64.4 years
STANDARD_DEVIATION 9.0 • n=7 Participants
65.4 years
STANDARD_DEVIATION 8.0 • n=5 Participants
Sex: Female, Male
Female
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Male
32 Participants
n=5 Participants
32 Participants
n=7 Participants
64 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
White
32 Participants
n=5 Participants
32 Participants
n=7 Participants
64 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
Italy
32 participants
n=5 Participants
32 participants
n=7 Participants
64 participants
n=5 Participants

PRIMARY outcome

Timeframe: Intraoperative at hourly intervals

body core temperature of patients undergoing robot-assisted radical prostatectomy (RARP), measured with a disposable esophageal probe

Outcome measures

Outcome measures
Measure
Group Humigard+Warming Blanket (H+WB)
n=32 Participants
32 patients will receive warmed, humidified CO2 insufflation with the Humigard® device, along with the hot air warming blanket used as a routine in our institution (forced air warming blanket at 38°C : Bear Hugger®) Humigard: warmed and humidified CO2 insufflation
Group Warming Blanket (WB)
n=32 Participants
32 patients will receive standard CO2 insufflation, along with the hot air warming blanket used as a routine in our institution (forced air warming blanket at 38°C : Bear Hugger® and a standard insufflation with non-humidified, non-heated CO2)
Intraoperative Change in Body Core Temperature
start of surgery
35.73 degrees °C
Standard Deviation 0.37
35.70 degrees °C
Standard Deviation 0.34
Intraoperative Change in Body Core Temperature
after 1h
35.78 degrees °C
Standard Deviation 0.42
35.77 degrees °C
Standard Deviation 0.37
Intraoperative Change in Body Core Temperature
after 2h
35.96 degrees °C
Standard Deviation 0.53
35.90 degrees °C
Standard Deviation 0.41
Intraoperative Change in Body Core Temperature
after 3h
36.11 degrees °C
Standard Deviation 0.60
36.07 degrees °C
Standard Deviation 0.52
Intraoperative Change in Body Core Temperature
after 4h
36.34 degrees °C
Standard Deviation 0.64
36.07 degrees °C
Standard Deviation 0.55
Intraoperative Change in Body Core Temperature
end of surgery
36.26 degrees °C
Standard Deviation 0.69
36.06 degrees °C
Standard Deviation 0.62

SECONDARY outcome

Timeframe: changes in cytokine levels measured just before induction of anesthesia, after 2 h of pneumoperitoneum, 2 h from exsufflation, and 24 h after surgery

mean levels of the pro-inflammatory cytokine interleukin-6 (IL-6) in patients undergoing robot-assisted radical prostatectomy (RARP), measured just before induction of anesthesia, after 2 h of pneumoperitoneum, 2 h from exsufflation, and 24 h after surgery

Outcome measures

Outcome measures
Measure
Group Humigard+Warming Blanket (H+WB)
n=32 Participants
32 patients will receive warmed, humidified CO2 insufflation with the Humigard® device, along with the hot air warming blanket used as a routine in our institution (forced air warming blanket at 38°C : Bear Hugger®) Humigard: warmed and humidified CO2 insufflation
Group Warming Blanket (WB)
n=32 Participants
32 patients will receive standard CO2 insufflation, along with the hot air warming blanket used as a routine in our institution (forced air warming blanket at 38°C : Bear Hugger® and a standard insufflation with non-humidified, non-heated CO2)
Cytokine Interleukin-6 (IL-6)
after 2h
4.61 IU
Standard Deviation 5.04
4.16 IU
Standard Deviation 3.5
Cytokine Interleukin-6 (IL-6)
2h from exsufflation
29.13 IU
Standard Deviation 24.18
25.91 IU
Standard Deviation 22.9
Cytokine Interleukin-6 (IL-6)
24h after surgery
27.01 IU
Standard Deviation 25.12
23.67 IU
Standard Deviation 25.8
Cytokine Interleukin-6 (IL-6)
start of surgery
2.13 IU
Standard Deviation 2.07
2.20 IU
Standard Deviation 2.2

SECONDARY outcome

Timeframe: changes in cytokine levels just before induction of anesthesia, after 2 h of pneumoperitoneum, 2 h from exsufflation, and 24 h after surgery

mean levels of the pro-inflammatory cytokine tumor necrosis factor (TNF)-beta in patients undergoing robot-assisted radical prostatectomy (RARP), measured just before induction of anesthesia, after 2 h of pneumoperitoneum, 2 h from exsufflation, and 24 h after surgery

Outcome measures

Outcome measures
Measure
Group Humigard+Warming Blanket (H+WB)
n=32 Participants
32 patients will receive warmed, humidified CO2 insufflation with the Humigard® device, along with the hot air warming blanket used as a routine in our institution (forced air warming blanket at 38°C : Bear Hugger®) Humigard: warmed and humidified CO2 insufflation
Group Warming Blanket (WB)
n=32 Participants
32 patients will receive standard CO2 insufflation, along with the hot air warming blanket used as a routine in our institution (forced air warming blanket at 38°C : Bear Hugger® and a standard insufflation with non-humidified, non-heated CO2)
Cytokine Tumor Necrosis Factor (TNF)-Beta
2h from exsufflation
5.44 IU
Standard Deviation 5.3
4.90 IU
Standard Deviation 4.5
Cytokine Tumor Necrosis Factor (TNF)-Beta
start of surgery
5.74 IU
Standard Deviation 4.8
6.29 IU
Standard Deviation 6.6
Cytokine Tumor Necrosis Factor (TNF)-Beta
after 2h
5.69 IU
Standard Deviation 5.8
5.20 IU
Standard Deviation 4.2
Cytokine Tumor Necrosis Factor (TNF)-Beta
24h after surgery
6.11 IU
Standard Deviation 5.7
7.24 IU
Standard Deviation 6.0

SECONDARY outcome

Timeframe: changes in postoperative pain measured at patient awakening and then every 30 min in the recovery room, until discharge to the ward. Successively, it was measured at 12, 24, and 48 h

postoperative pain in patients undergoing robot-assisted radical prostatectomy (RARP) as measured by the Numeric Pain Rating Score (NRS), measured at patient awakening and after 12, 24, and 48 h from surgery. NRS goes from 0 to 10, where 0 means no pain and 10 the maximum pain possible.

Outcome measures

Outcome measures
Measure
Group Humigard+Warming Blanket (H+WB)
n=32 Participants
32 patients will receive warmed, humidified CO2 insufflation with the Humigard® device, along with the hot air warming blanket used as a routine in our institution (forced air warming blanket at 38°C : Bear Hugger®) Humigard: warmed and humidified CO2 insufflation
Group Warming Blanket (WB)
n=32 Participants
32 patients will receive standard CO2 insufflation, along with the hot air warming blanket used as a routine in our institution (forced air warming blanket at 38°C : Bear Hugger® and a standard insufflation with non-humidified, non-heated CO2)
Postoperative Pain
At 12 hours
1.6 Units on a scale
Standard Deviation 1.8
1.9 Units on a scale
Standard Deviation 2.2
Postoperative Pain
Patient awakening
2.5 Units on a scale
Standard Deviation 2.6
2.3 Units on a scale
Standard Deviation 2.8
Postoperative Pain
At 24 hours
1.3 Units on a scale
Standard Deviation 1.5
1.8 Units on a scale
Standard Deviation 2.1
Postoperative Pain
At 48 hours
0.6 Units on a scale
Standard Deviation 1.1
1.1 Units on a scale
Standard Deviation 1.9

Adverse Events

Group H+WB

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Group WB

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Marco Oderda

Città della Salute e della Scienza di Torino - Ospedale Molinette

Phone: +393479383465

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place